L-threo-Ritalinic acid is a stereochemically defined piperidine derivative and a major metabolite of methylphenidate. It serves as a pharmaceutical intermediate in the manufacturing of methylphenidate, featuring both an aromatic ring and an amino acid functional group.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 54631-24-2
Neomycin EP Impurity G
Pharmaceutical impurity reference standard
(6R,7R)-Benzhydryl 3-hydroxy-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Cephalosporin intermediate
6-Chloro-4-(2-chlorophenyl)-2-quinazolinecarboxylic Acid
Pharmaceutical impurity intermediate
Aminoacetonitril siran
pharmaceutical intermediate
D-erythro-Ritalinic Acid
research compound
D-threo-Ritalinic Acid
active pharmaceutical ingredient
2-Phenyl-2-(piperidin-2-yl)acetic acid hydrochloride
Pharmaceutical intermediate
Ritalinik asit
pharmaceutical intermediate
(2S)-2-phenyl-2-[(2S)-piperidin-2-yl]acetic acid
INGSNVSERUZOAK-RYUDHWBXSA-N
C1CCN[C@@H](C1)[C@H](C2=CC=CC=C2)C(=O)O